All Access Articles |
- Arvinas, Inc. Submits NDA for Vepdegestrant | 2025-06-06 | PHARMACEUTICAL
- Arvinas' Arv-102 Shows Promising Results in First-in-Human Trial | 2025-04-04 | PHARMACEUTICAL
- Arvinas Reports $227.1M Decrease in Cash for 2024 | 2025-02-11 | PHARMACEUTICAL